hCG-hLH receptor and hCG-hLH receptor-hCG complex as antigens, a

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530398, 530399, 530350, 435 701, 435 703, 514 8, 514 12, 424 88, A61K 3700, A61K 3738, A61K 3729, A61K 3736

Patent

active

049668889

ABSTRACT:
Purified hCG-hLH receptor, hCG-hLH receptor-hCG complex and combinations between their subunits as antigens, as well as antibodies thereto which are useful as a contraceptive vaccine.

REFERENCES:
patent: 4016250 (1977-04-01), Saxena
patent: 4161519 (1979-07-01), Talwar
patent: 4310455 (1982-01-01), Bahl
patent: 4560649 (1985-12-01), Satena et al.
Satena, Brij, Methods Mol. Biol., vol. 9, pt. 1, pp. 251-299, 1976 (see pp. 275-280 especially).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

hCG-hLH receptor and hCG-hLH receptor-hCG complex as antigens, a does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with hCG-hLH receptor and hCG-hLH receptor-hCG complex as antigens, a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and hCG-hLH receptor and hCG-hLH receptor-hCG complex as antigens, a will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-275340

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.